309 related articles for article (PubMed ID: 18335649)
1. A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin.
McCullough JL; Garcia RL; Reece B
J Drugs Dermatol; 2008 Feb; 7(2):131-5. PubMed ID: 18335649
[TBL] [Abstract][Full Text] [Related]
2. Novel Topical Cytokinin Improves Coarse Wrinkles and Skin Roughness Without Skin Irritation.
Garcia RL; McCullough JL; Reece B; Massino FJ
J Drugs Dermatol; 2018 Jul; 17(7):772-779. PubMed ID: 30005100
[TBL] [Abstract][Full Text] [Related]
3. Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea.
Ortiz A; Elkeeb L; Truitt A; Hindiyeh R; Aquino L; Tran M; Weinstein G
J Drugs Dermatol; 2009 May; 8(5):459-62. PubMed ID: 19537369
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of topical PRK 124 (0.125%) lotion (Pyratine-XR) in the treatment of mild-to-moderate rosacea.
Tremaine AM; Ortiz A; Elkeeb L; Tran M; Weinstein G
J Drugs Dermatol; 2010 Jun; 9(6):647-50. PubMed ID: 20645526
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations.
Gold MH; Gallagher C
J Drugs Dermatol; 2013 Dec; 12(12):1468-72. PubMed ID: 24301250
[TBL] [Abstract][Full Text] [Related]
7. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel.
Sefton J; Kligman AM; Kopper SC; Lue JC; Gibson JR
J Am Acad Dermatol; 2000 Oct; 43(4):656-63. PubMed ID: 11004622
[TBL] [Abstract][Full Text] [Related]
8. Topical manganese peptide in the treatment of photodamaged skin.
Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2007 Dec; 9(4):232-6. PubMed ID: 18236243
[TBL] [Abstract][Full Text] [Related]
9. Topical tretinoin for treatment of photodamaged skin. A multicenter study.
Weinstein GD; Nigra TP; Pochi PE; Savin RC; Allan A; Benik K; Jeffes E; Lufrano L; Thorne EG
Arch Dermatol; 1991 May; 127(5):659-65. PubMed ID: 2024983
[TBL] [Abstract][Full Text] [Related]
10. A novel treatment option for photoaged skin.
Knott A; Koop U; Mielke H; Reuschlein K; Peters N; Muhr GM; Lenz H; Wensorra U; Jaspers S; Kolbe L; Raschke T; Stäb F; Wenck H; Gallinat S
J Cosmet Dermatol; 2008 Mar; 7(1):15-22. PubMed ID: 18254806
[TBL] [Abstract][Full Text] [Related]
11. Change of biophysical properties of the skin caused by ultraviolet radiation-induced photodamage in Koreans.
Lim SH; Kim SM; Lee YW; Ahn KJ; Choe YB
Skin Res Technol; 2008 Feb; 14(1):93-102. PubMed ID: 18211607
[TBL] [Abstract][Full Text] [Related]
12. Treatment of facial photodamage using a novel retinol formulation.
Gold MH; Kircik LH; Bucay VW; Kiripolsky MG; Biron JA
J Drugs Dermatol; 2013 May; 12(5):533-40. PubMed ID: 23652947
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
McDaniel DH; Neudecker BA; DiNardo JC; Lewis JA; Maibach HI
J Cosmet Dermatol; 2005 Sep; 4(3):167-73. PubMed ID: 17129261
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin.
Barel A; Calomme M; Timchenko A; De Paepe K; Demeester N; Rogiers V; Clarys P; Vanden Berghe D
Arch Dermatol Res; 2005 Oct; 297(4):147-53. PubMed ID: 16205932
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
16. A controlled multi-center study evaluating the efficacy of Vivité skin care in the treatment of photoaging of the face, eye and mouth.
Goldman MP; Gold MH
J Drugs Dermatol; 2010 Jan; 9(1):22-6. PubMed ID: 20120421
[TBL] [Abstract][Full Text] [Related]
17. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
18. Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin.
Berardesca E; Abril E; Serio M; Cameli N
Int J Cosmet Sci; 2009 Aug; 31(4):271-7. PubMed ID: 19496838
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
[TBL] [Abstract][Full Text] [Related]
20. Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
Machtinger LA; Kaidbey K; Lim J; Loven KH; Rist TE; Wilson DC; Parizadeh DD; Sefton J; Holland JM; Walker PS
Br J Dermatol; 2004 Dec; 151(6):1245-52. PubMed ID: 15606521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
